Review Article

Relationship between Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies

Table 1

Baseline characteristics of subclinical thyroid dysfunction in included studies.

First author, yearSampleMean age (range) (y)Follow-upTSH cutoff value (mIU/L) (Shypo/Shyper)Thyroxine measured (Shypo/Shyper)Exclusion of thyroid hormone/antithyroid drug recipientsOutcome (Shypo or Shyper)

Parle et al. [43]118770.4 (>60)8.2 y>5.0/<0.44Yes/yesYes/yesCHD, CHD mortality, total, and cardiovascular mortality
Gussekloo et al. [42]527853.7 y>4.8/<0.3Yes/yesYes/yesCHD, CHD mortality, total, and cardiovascular mortality
Rodondi et al. [41]273074.7 (70–79)4 y≥4.5/NAYes/NANR/NACHD, HF, total, and cardiovascular mortality
Walsh et al. [24]189049.8 (17–89)20 y>4.0/<0.4Yes/yesNR/NRCHD and cardiovascular mortality
Cappola et al. [23]318272.7 (≥65)12.5 y>4.5/<0.45Yes/yesYes/yesCHD, AF, total, and cardiovascular mortality
Bauer et al. [40]48771.7 (≥65)11.9 y>5.5/≤0.5NR/NRNR/NRTotal and cardiovascular mortality
Rodondi et al. [39]304472.6 (≥65)15 y>4.5/<0.45Yes/yesYes/yesHF
Razvi et al. [38]235045.4 (18–92)20 y>6/NANR/NAYes/NACHD, CHD mortality, and total mortality
Boekholdt et al. [5]13,14158 (45–79)10.6 y>4/<0.4Yes/yesYes/yesCHD, CHD mortality, and total mortality
Ittermann et al. [44]388348.9 (20–79)8.5 yNA/<0.25NA/yesNA/yesCHD, CHD mortality, AF, and total mortality
Jongh et al. [21]119775.5 (>65)10.7 y>4.5/<0.3Yes/yesYes/yesCHD, CHD mortality, total, and cardiovascular mortality
Schultz et al. [35]60567.8 (50–91)5 y>4/<0.4Yes/yesNR/NRTotal mortality
Nanchen et al. [33]531675 (70–82)3.2 y≥4.5/<0.45Yes/yesYes/yesCHD, HF, AF, total, and cardiovascular mortality
Asvold et al. [34]26,47553.712.3 y>3.6/<0.49Yes/yesNR/NRCHD, CHD mortality, and HF
Ceresini et al. [32]93175.5 (>65)6 y>4.68/<0.49Yes/yesYes/yesTotal mortality
Hyland et al. [31]486373.5 (>65)10 y>4.5/NAYes/NANR/NACHD, cardiovascular mortality, and HF

Shypo: subclinical hypothyroidism; Shyper: subclinical hyperthyroidism; CHD: coronary heart disease; AF: atrial fibrillation; HF: heart failure; TSH: thyroid-stimulating hormone; NR: not reported; NA: not applicable (because the outcome was not examined in the study).